The "Rags-To-Riches" Portfolio: An Update
Image Source: Unsplash
Cannabis, psychedelic, and plant-based food stocks performed extremely poorly in 2022, DOWN 73% vs. 2021 but perhaps some of them will bounce back with major returns in 2023. munKNEE.com tracks the performance of the largest Canadian cannabis LPs, American cannabis MSOs, psychedelic drug stocks and plant-based food stocks in four separate indexes on a weekly basis and the munKNEE "Rags-to-Riches" Portfolio consists of the 14 stocks in those indexes with market capitalizations between $400M and $3.0B - an average of $968M. The munKNEE "Multi-bagger" Portfolio, in comparison, consists of the remaining 12 stocks in the same four indexes but with market capitalizations between $100M and $399M with am average of $136M.
Below is an update on how the various categories in the Portfolio, and their constituents, have performed month-to-date (MTD) and year-to-date (YTD).
- American Cannabis MSO constituents:
- Cresco (CRLBF): DOWN 3.5% MTD; DOWN 4.6% YTD;
- Curaleaf (CURLF): DOWN 5.8% MTD; DOWN 13.0% YTD;
- Green Thumb (GTBIF): DOWN 1.8% MTD; DOWN 3.3% YTD;
- TerrAscend (TRSSF): DOWN 4.5% MTD; UP 36.4% YTD;
- Trulieve (TCNNF): DOWN 4.5% MTD; DOWN 18.8% YTD; and
- Verano (VRNOF): No Change MTD; DOWN 3.9% YTD.
- In total: DOWN 3.2% MTD; DOWN 7.8% YTD.
- For comparison purposes, the AdvisorShares Pure U.S. Cannabis ETF (MSOS) is DOWN 3.4% MTD and is DOWN 10.0% YTD.
- Canadian Cannabis LP constituents:
- Psychedelic Drug Stock constituents:
- Plant-Based Food Stock constituents:
In Conclusion
- The "Rags-to-Riches" Portfolio is -8.6% MTD and -3.7% YTD,
- the S&P 500 is only -1.4% MTD and is +2.0% YTD
- and our "Multi-bagger" Portfolio is +0.6% MTD and -8.6 % YTD.
More By This Author:
Planet 13: Eight Analysts Forecast An Average Upside Of 94% Within 12 Months
Cresco Labs: Across-The-Board Negative Q4 Financial Metrics
Aurora Cannabis: 14 Analysts Only See An 80% Upside In Next Year
Disclosure: None
Visit munKNEE.com and register to receive our free Market Intelligence Report newsletter (sample more